Top Markets
#1 Derive Derive +34.71%
#2 Cross Cross +19.12%
#3 Geodnet Geodnet +11.72%
#4 Palladium Network Palladium Network +11.56%
#5 Gama Token Gama Token +9.18%
#6 The Bitcoin Bull The Bitcoin Bull +8.57%
#7 Biconomy Biconomy +8.06%
#8 Quantum Resistant Ledger Quantum Resistant Ledger +7.74%
#9 Steakhouse ETH Morpho Vault Steakhouse ETH Morpho Vault +7.00%
#10 Humanity Humanity +6.54%
Coin of the day
Derive Derive
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Medican Enterprises, Inc. Medican Enterprises, Inc.

Medican Enterprises, Inc.

MDCN
Clasificación en acciones #36247
Medican Enterprises, Inc. is a bio-pharmaceutical company, which engages in the... Medican Enterprises, Inc. is a bio-pharmaceutical company, which engages in the production, cultivation, and wholesale distribution of cannabis related products. The company was founded on October 27, 1988 and is headquartered in Los Angeles, CA.
Precio por acción
$0.0001
Última sincronización: 2026-08-13
Capitalización bursátil
$2.88M
Cambio (1 día)
0.00%
Cambio (1 año)
0.00%
País
US
Comercio Medican Enterprises, Inc. (MDCN)

Categoría

Healthcare
Ratio P/B de Medican Enterprises, Inc. (MDCN)
Ratio P/B al 2026 TTM: 0
Según los informes financieros más recientes y el precio de las acciones de Medican Enterprises, Inc., el ratio P/B actual (TTM) es 0. Al final de 2026, el ratio P/B era 0.
Historial del ratio P/B de Medican Enterprises, Inc. desde 2026 hasta 2026
Ratio P/B al final de cada año
Año Ratio P/B Cambiar
Not enough data for the provided dates.
Ratio P/B de empresas similares o competidoras
Empresa Ratio P/B Diferencia del ratio P/B País
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
 3.817 -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
 - -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
 - -
FR
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
 - -
IT
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
 17.0911 -
US